Neurotoxicity

Biomarkable bvba – Update: 3 January 2013
 
  • Van Gool SW, Van Kerschaver E, Brock P, Pottel H, Hulstaert F, Vanmechelen E, Uyttebroeck A, Van De Voorde A, Vanderstichele H. Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies. Leukemia 2000; 14: 2076-2084.

  • Van Gool S, De Meyer G, Van de Voorde A, Vanmechelen E, Vanderstichele H. Neurotoxicity marker profiles in the CSF are not age-dependent but show variation in children treated for Acute Lymphoblastic Leukemia. Neurtoxicology 2004; 25: 471-480

  • de Bont JM, Vanderstichele H, Reddingius RE, Pieters R, van Gool SW. Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients. Eur J Paediatr Neurol 2008; 12:334-341.

 
Publications ⇑